Skip to main content

Voya Financial, Inc.

For the period ended Dec 31, 2025. Filed Feb 20, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 20, 2026

VOYA$104.59+5.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

13. Earnings per Common Share

  1. Earnings per Common Share

The following table presents a reconciliation of Net income and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated:

(in millions, except for per share data)Year Ended December 31,
Earnings202520242023
Net income available to common shareholders:
Net income$733$742$729
Less: Preferred stock dividends414136
Less: Net income attributable to noncontrolling interest and redeemable noncontrolling interest7975104
Net income available to Voya Financial, Inc.'s common shareholders$613$626$589
Weighted-average common shares outstanding
Basic95.899.2102.7
Dilutive Effects:
Warrants(1)——3.3
RSUs1.01.11.2
PSUs0.40.71.1
Stock Options0.20.40.5
Diluted97.4101.4108.8
Net income available to Voya Financial, Inc.'s common shareholders per common share(2)
Basic$6.40$6.31$5.74
Diluted$6.29$6.17$5.42

(1)See the Shareholders' Equity Note to these Consolidated Financial Statements for additional information on warrants settled.

(2)Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total. Diluted earnings per share is computed assuming the issuance of restricted stock units, stock options, performance share units and warrants using the treasury stock method.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.